Zimmer Biomet Holdings Inc (ZBH) stock price

Zimmer Biomet Holdings Inc (ZBH) is a Healthcare · Medical Devices company listed on NYSE. Price $95.70 (+1.54%), Market cap $16.65B, P/E ratio 22.30, 52-week low–high $79.58 ~ $107.71.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformiti

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Zimmer Biomet Holdings Inc are updated in real time on BlackAll Trade.

Zimmer Biomet Holdings Inc financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Zimmer Biomet Holdings Inc (ZBH) stock price?

Zimmer Biomet Holdings Inc trades at $95.70 (+1.54%). Real-time quotes and charts are available on BlackAll Trade.

What is the Zimmer Biomet Holdings Inc (ZBH) market cap?

Zimmer Biomet Holdings Inc has a market cap of about $16.65B. Its P/E ratio is 22.30.

What does Zimmer Biomet Holdings Inc (ZBH) do?

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, suc